Clinical trial
Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (Compassionate Use)
NCT02084121
Study timeline
Registry last updated2022-07-18
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metachromatic Leukodystrophyunresolved
Interventions
Enriched Hematopoetic Stem Cell InfusionBIOLOGICAL
Sponsors & collaborators
Talaris Therapeutics Inc.lead sponsor
Duke Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02084121 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.